Clinical trial
Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg
NCT01376115 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 18, 2008
- Completion date
- October 24, 2017
- Enrollment
- 343 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer